Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelines Collaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D ...
Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Franklin Biolabs, a fully integrated preclinical contract research organization (CRO) at the forefront of genetic medicine and biologics innovation, and RareMoon Consulting, a regulatory services ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Fractyl Health to present preclinical data on gene therapy for obesity and type 2 diabetes at ADA’s Scientific Sessions. Fractyl Health, Inc. has announced it will present new preclinical data from ...
Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/M ...
Evotec SE, a life science company that is pioneering the future of drug discovery and development, announced the nomination of a small molecule preclinical development candidate (PDC) from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results